Posts Tagged ‘DEA’
Time for a Cannabis Policy Reset
Time for a Cannabis Policy Reset: Outdated Regulations Are Fueling the Illicit Market State cannabis regulators are still operating under rules designed for a brand-new industry—and that’s become a big problem. Instead of helping the legal cannabis market thrive, these outdated frameworks are making it harder for licensed businesses to survive. Meanwhile, the illicit…
Read MoreCannabis Industry and University Partnerships: What 2025 Could Bring
Cannabis Industry and University Partnerships: What 2025 Could Bring The cannabis industry is gearing up for some exciting changes in 2025, with partnerships between cannabis businesses and universities expected to flourish. While academic collaborations aren’t new, the cannabis sector has been slow to embrace them — mainly due to marijuana’s status as a federally illegal…
Read MoreDEA Delays Hinder Medical Cannabis Progress
DEA Delays Hinder Medical Cannabis Progress MMJ International Holdings is leading efforts in marijuana-derived pharmaceuticals for Huntington’s disease and multiple sclerosis, with FDA support. However, the DEA’s prolonged delays in processing cultivation applications have become a major hurdle. Regulatory Roadblocks Despite federal mandates to expand cannabis research, DEA senior policy adviser Matthew J. Strait has…
Read MoreNavigating in Cannabis Insurance
Navigating Cannabis Insurance: What You Need to Know Running a cannabis business comes with unique challenges due to the clash between state and federal laws. While many states have legalized cannabis, it’s still illegal at the federal level. This conflict impacts everything from insurance options to policy structure and coverage limits. PM Insurance Services can…
Read More